Euclidean Capital LLC Surrozen, Inc. Transaction History

Euclidean Capital LLC

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 01, 2023
BUY
$0.44 - $0.89 $225,500 - $456,125
512,500 Added 63.83%
1,315,463 $644,000
Q1 2022

May 16, 2022
SELL
$2.2 - $6.01 $2 - $6
-1 Reduced -0.0%
802,963 $2.42 Million
Q4 2021

Feb 14, 2022
SELL
$6.0 - $9.92 $6 - $9
-1 Reduced -0.0%
802,964 $5.17 Million
Q3 2021

Nov 15, 2021
BUY
$6.98 - $12.03 $5.6 Million - $9.66 Million
802,965 New
802,965 $5.69 Million

Others Institutions Holding SRZN

# of Institutions
3
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Surrozen, Inc.

SRZN Quotes by TradingView
  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $371M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Euclidean Capital LLC Portfolio

Follow Euclidean Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email